Medipharm Labs Corp (LABS.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 420 | 419 | 425 | 561 | 518 |
| Accounts receivable | 286 | -230 | -281 | -793 | -473 |
| Other Working Capital | 1,370 | 272 | -3,397 | 821 | 878 |
| Other Operating Activity | -2,234 | -3,230 | 241 | -1,656 | -1,585 |
| Operating Cash Flow | $-158 | $-2,769 | $-3,012 | $-1,067 | $-662 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 35 | 0 | 0 | 0 | 0 |
| Other Investing Activity | 424 | 4,203 | -42 | -44 | -33 |
| Investing Cash Flow | $459 | $4,203 | $-42 | $-44 | $-33 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 0 | 50 |
| Debt Repayment | -428 | 224 | -265 | 2,578 | -2,292 |
| Other Financing Activity | 355 | 223 | 56 | -2,822 | 20 |
| Financing Cash Flow | $-73 | $447 | $-209 | $-244 | $-2,222 |
| Exchange Rate Effect | -6 | 38 | 16 | -47 | 18 |
| Beginning Cash Position | 10,362 | 8,443 | 11,690 | 13,092 | 15,991 |
| End Cash Position | 10,584 | 10,362 | 8,443 | 11,690 | 13,092 |
| Net Cash Flow | $228 | $1,881 | $-3,263 | $-1,355 | $-2,917 |
| Free Cash Flow | |||||
| Operating Cash Flow | -158 | -2,769 | -3,012 | -1,067 | -662 |
| Capital Expenditure | -16 | -42 | -42 | -44 | -33 |
| Free Cash Flow | -174 | -2,811 | -3,054 | -1,111 | -695 |